{
    "organizations": [],
    "uuid": "69c2a271a5f303da01c509dc330b30bb9b84e736",
    "author": "",
    "url": "https://www.reuters.com/article/brief-merck-announces-q1-gaap-eps-of-027/brief-merck-announces-q1-gaap-eps-of-0-27-idUSASC09YI6",
    "ord_in_thread": 0,
    "title": "BRIEF-Merck Announces Q1 GAAP EPS Of $0.27",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1, 2018 / 11:16 AM / Updated 6 minutes ago BRIEF-Merck Announces Q1 GAAP EPS Of $0.27 Reuters Staff\nMay 1 (Reuters) - Merck & Co Inc:\n* MERCK ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS * Q1 GAAP EARNINGS PER SHARE $0.27\n* Q1 EARNINGS PER SHARE VIEW $1.00 — THOMSON REUTERS I/B/E/S\n* Q1 NON-GAAP EARNINGS PER SHARE $1.05\n* NARROWS AND RAISES 2018 FULL-YEAR REVENUE RANGE TO BE BETWEEN $41.8 BILLION AND $43.0 BILLION\n* FIRST-QUARTER 2018 GAAP EPS WAS $0.27, REFLECTING A $1.4 BILLION AGGREGATE CHARGE RELATED TO FORMATION OF A COLLABORATION WITH EISAI * LOWERS 2018 GAAP EPS RANGE TO BE BETWEEN $2.45 AND $2.57\n* NARROWS AND RAISES 2018 FULL-YEAR NON-GAAP EPS RANGE TO BE BETWEEN $4.16 AND $4.28\n* QTRLY JANUVIA/JANUMET SALES $1,424 MILLION VERSUS $1,335 MILLION REPORTED LAST YEAR\n* FIRST-QUARTER PHARMACEUTICAL SALES INCREASED 9 PERCENT TO $8.9 BILLION, INCLUDING A 5 PERCENT POSITIVE IMPACT FROM FOREIGN EXCHANGE\n* QTRLY KEYTRUDA SALES $1,464 MILLION VERSUS $584 MILLION REPORTED LAST YEAR\n* FIRST-QUARTER 2018 WORLDWIDE SALES WERE $10.0 BILLION, AN INCREASE OF 6 PERCENT\n* QTRLY REMICADE SALES $167 MILLION VERSUS $229 MILLION REPORTED LAST YEAR * Q1 REVENUE VIEW $10.11 BILLION — THOMSON REUTERS I/B/E/S\n* FY2018 EARNINGS PER SHARE VIEW $4.20, REVENUE VIEW $41.89 BILLION — THOMSON REUTERS I/B/E/S\n* QTRLY PHARMACEUTICAL SALES INCREASE WAS PRIMARILY DRIVEN BY GROWTH IN ONCOLOGY, HOSPITAL ACUTE CARE AND DIABETES\n* MERCK - PHARMACEUTICAL SALES GROWTH IN QUARTER WAS PARTIALLY OFFSET BY LOWER SALES IN VIROLOGY, LARGELY REFLECTING A SIGNIFICANT DECLINE IN ZEPATIER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-05-01T14:15:00.000+03:00",
    "crawled": "2018-05-01T14:28:52.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "announces",
        "q1",
        "gaap",
        "eps",
        "reuters",
        "staff",
        "may",
        "reuters",
        "merck",
        "co",
        "inc",
        "merck",
        "announces",
        "financial",
        "result",
        "q1",
        "gaap",
        "earnings",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "narrow",
        "raise",
        "revenue",
        "range",
        "billion",
        "billion",
        "gaap",
        "eps",
        "reflecting",
        "billion",
        "aggregate",
        "charge",
        "related",
        "formation",
        "collaboration",
        "eisai",
        "lower",
        "gaap",
        "eps",
        "range",
        "narrow",
        "raise",
        "eps",
        "range",
        "qtrly",
        "sale",
        "million",
        "versus",
        "million",
        "reported",
        "last",
        "year",
        "pharmaceutical",
        "sale",
        "increased",
        "percent",
        "billion",
        "including",
        "percent",
        "positive",
        "impact",
        "foreign",
        "exchange",
        "qtrly",
        "keytruda",
        "sale",
        "million",
        "versus",
        "million",
        "reported",
        "last",
        "year",
        "worldwide",
        "sale",
        "billion",
        "increase",
        "percent",
        "qtrly",
        "remicade",
        "sale",
        "million",
        "versus",
        "million",
        "reported",
        "last",
        "year",
        "q1",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "fy2018",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "billion",
        "thomson",
        "reuters",
        "qtrly",
        "pharmaceutical",
        "sale",
        "increase",
        "primarily",
        "driven",
        "growth",
        "oncology",
        "hospital",
        "acute",
        "care",
        "diabetes",
        "merck",
        "pharmaceutical",
        "sale",
        "growth",
        "quarter",
        "partially",
        "offset",
        "lower",
        "sale",
        "virology",
        "largely",
        "reflecting",
        "significant",
        "decline",
        "zepatier",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}